| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191188 | Annals of Allergy, Asthma & Immunology | 2014 | 7 Pages |
Abstract
Omalizumab has exceptional efficacy for antihistamine-resistant CSU with an excellent adverse effect profile.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Allen P. MD,